Catalyst Pharmaceuticals CPRX
CPRX
$31.49 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Catalyst Pharmaceuticals (CPRX) Accumulated Expenses (2010 - 2026)

Updated

Catalyst Pharmaceuticals (CPRX) reported Accumulated Expenses of $125.25 million for Q1 2026, up 24.7% from $100.45 million a year earlier but down 7.9% from the prior quarter.

Analysis

Catalyst Pharmaceuticals (CPRX) Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025, Catalyst Pharmaceuticals posted Accumulated Expenses of $135.95 million, up 30.6% from FY2024.

  • Accumulated Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 49.0% (FY2020 to FY2025).
  • By year, Accumulated Expenses came in at $104.09 million in FY2024 (+69.9%), $61.27 million in FY2023 (+14.3%), $53.61 million in FY2022 (+120.7%) and $24.3 million in FY2021 (+31.3%).
  • Five-year quarterly Accumulated Expenses spans a low of $13.21 million in Q2 2021 and a high of $135.95 million in Q4 2025.
  • Year over year, Accumulated Expenses has now increased in each of the last 19 quarters, with growth averaging 47.2% over the last eight quarters.
  • The high point for year-over-year Accumulated Expenses in five years was Q1 2023 (growth of 199.6%); the low point was Q2 2021 (a decline of 8.3%).
  • Per Business Quant data, the three quarters before Q1 2026 came in at $135.95 million (Q4 2025), $119.64 million (Q3 2025) and $107.48 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Catalyst Pharmaceuticals 3.85 Bn 1.04 Bn 134.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 125.25 Mn
Dec 31, 2025 135.95 Mn
Sep 30, 2025 119.64 Mn
Jun 30, 2025 107.48 Mn
Mar 31, 2025 100.45 Mn
Dec 31, 2024 104.09 Mn
Sep 30, 2024 93.83 Mn
Jun 30, 2024 85.20 Mn
Mar 31, 2024 69.31 Mn
Dec 31, 2023 61.27 Mn
Sep 30, 2023 53.21 Mn
Jun 30, 2023 48.08 Mn
Mar 31, 2023 53.32 Mn
Dec 31, 2022 53.61 Mn
Sep 30, 2022 42.15 Mn
Jun 30, 2022 20.17 Mn
Mar 31, 2022 17.80 Mn
Dec 31, 2021 24.30 Mn
Sep 30, 2021 17.86 Mn
Jun 30, 2021 13.21 Mn
API Access

Catalyst Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CPRX&period=max&api_key=YOUR_API_KEY